ArborGen receives second PPP loan
To: NZX From: Sharon Ludher-Chandra
Further information on ArborGen Holdings Limited can be viewed at our web site http://www.arborgenholdings.com.
ArborGen receives second PPP loan
2 March 2021
ArborGen Holdings announced today that its wholly owned subsidiary in the US, ArborGen Inc., has
received approval and funding from the Small Business Administration (SBA) under the CARES Act
Paycheck Protection Program (PPP) for a second loan in the amount of US$1.95 million. The funds are
to be used to fund payroll costs including benefits and other business related costs due to the
uncertainties caused by COVID-19.
The SBA will forgive loans if all employees are kept on the payroll for eight weeks and the money is
used for payroll costs, rent, mortgage interest, or utilities payments over the 8 weeks after receiving
the loan. At least 60% of the forgiven amount must have been used for payroll costs which includes
employee salaries, hourly wages, sick or medical leave, and group health insurance premiums.
As announced previously, ArborGen applied for a PPP loan early last year, subsequently receiving
$2.335 million in May 2020. This funding allowed ArborGen to retain all employees and avoid any lay-
offs during a period of significant uncertainty. ArborGen applied for forgiveness of this first PPP loan
in accordance with the guidelines late last year. While this forgiveness application is still being
processed, ArborGen believes it has provided the documents necessary to support the full forgiveness
of the loan.
ArborGen
ArborGen is the largest commercial global seedling supplier and a leading provider of advanced genetics, for the
forest industry. Employing state-of-the-art technology, ArborGen is developing high-value products that
significantly improve the productivity of a given acre of land by enabling our customers to grow trees that yield
more wood per acre with greater consistency and quality in a shorter period of time. For more information, please
visit ArborGen’s website at www.arborgen.com.
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- GEN — General Capital Limited: General Capital continues on its strong growth path2021-05-30
“General Capital Limited Level 8, General Capital House, 115 Queen Street, Auckland CBD PO Box 1314, Shortland Street, Auckland, New Zealand. 1140. Phone +64 9 304 0145 Fax +64 9 358 3858 General Capital (GEN:NZ) continues on its strong growth path General Capital Limi…”
- BRM — Barramundi Limited: BRM – March 2021 monthly update2021-03-14
“SECTOR SPLIT as at 28 February 2021 KEY DETAILS as at 28 February 2021 FUND TYPE Listed Investment Company INVESTS IN Growing Australian companies LISTING DATE 26 October 2006 FINANCIAL YEAR END 30 June TYPICAL PORTFOLIO SIZE 20-35 stocks INVESTMENT CRITERIA Long-term growth…”
- AFT — AFT Pharmaceuticals Limited: AFT delivers growth amid global disruptions2021-05-23
“Results for announcement to the market AFT Pharmaceuticals Limited Reporting Period 12 months to 31 March 2021 Previous Reporting Period 12 months to 31 March 2020 Currency NZ$ Amount (000s) Percentage change Revenue from continuing operations $113,105 Up 7% Tota…”